GeneHealth - Your precision medicine

Vitamin K Deficiency

Disease Details

Family Health Simplified

Buy Membership

Description: Vitamin K deficiency is a condition where the body lacks sufficient vitamin K, leading to impaired blood clotting and increased risk of bleeding.
Type: Vitamin K deficiency is not a genetic disorder but rather a condition caused primarily by inadequate dietary intake, poor absorption, or use of certain medications. Therefore, it is not transmitted genetically.
Signs And Symptoms: Symptoms include bruising, petechiae, and haematoma.
Vitamin K is changed to its active form in the liver by the enzyme Vitamin K epoxide reductase. Activated vitamin K is then used to gamma carboxylate (and thus activate) certain enzymes involved in coagulation: Factors II, VII, IX, X, and protein C and protein S. Inability to activate the clotting cascade via these factors leads to the bleeding symptoms mentioned above.Notably, when one examines the lab values in Vitamin K deficiency [see below] the prothrombin time is elevated, but the partial thromboplastin time is normal or only mildly prolonged. This may seem counterintuitive given that the deficiency leads to decreased activity in factors of both the intrinsic pathway (F-IX) which is monitored by PTT, as well as the extrinsic pathway (F-VII) which is monitored by PT. However, factor VII has the shortest half-life of all the factors carboxylated by vitamin K; therefore, when deficient, it is the PT that rises first, since the activated Factor VII is the first to "disappear." In later stages of deficiency, the other factors (which have longer half lives) are able to "catch up," and the PTT becomes elevated as well.
Prognosis: Prognosis for vitamin K deficiency:
The prognosis for vitamin K deficiency is generally good if diagnosed and treated promptly. Vitamin K supplementation can effectively correct the deficiency and prevent complications. If left untreated, however, severe deficiencies can lead to serious bleeding disorders, such as hemorrhagic disease of the newborn or spontaneous bleeding in adults, which can be life-threatening.

Nan:
Sorry, I am unable to interpret "nan" in this context. If you could provide more details or clarify the term, I would be glad to assist you further.
Onset: Vitamin K deficiency can lead to an onset of symptoms that typically manifest as bleeding tendencies. This includes easy bruising, bleeding gums, nosebleeds, blood in the urine or stool, and in severe cases, hemorrhaging. The onset of these symptoms is often gradual and may depend on the severity of the deficiency and individual health factors.
Prevalence: The prevalence of vitamin K deficiency can vary depending on the population and factors such as age, diet, and underlying health conditions. It is uncommon in healthy adults due to adequate dietary intake and the body's ability to recycle vitamin K. However, it is more prevalent in newborns, particularly those who do not receive prophylactic vitamin K at birth, and in individuals with conditions that affect fat absorption, such as celiac disease, cystic fibrosis, and certain liver diseases.
Epidemiology: The prevalence of vitamin K deficiency varies by geographic region. For infants in the United States, vitamin K1 deficiency without bleeding may occur in as many as 50% of infants younger than 5 days old, with the classic hemorrhagic disease occurring in 0.25-1.7% of infants. Therefore, the Committee on Nutrition of the American Academy of Pediatrics recommends that 0.5 to 1.0 mg Vitamin K1 be administered to all newborns shortly after birth.Postmenopausal and elderly women in Thailand have high risk of Vitamin K2 deficiency, compared with the normal value of young, reproductive females.
Current dosage recommendations for Vitamin K may be too low. The deposition of calcium in soft tissues, including arterial walls, is quite common, especially in those who have atherosclerosis, suggesting that Vitamin K deficiency is more common than previously thought.Because colonic bacteria synthesize a significant portion of the Vitamin K required for human needs, individuals with disruptions to or insufficient amounts of these bacteria can be at risk for Vitamin K deficiency. Newborns, as mentioned above, fit into this category, as their colons are frequently not adequately colonized in the first five to seven days of life. Another at-risk population comprises those individuals on any sort of long-term antibiotic therapy, as this can diminish the population of normal gut flora.
Intractability: Vitamin K deficiency is generally not considered intractable. It can usually be managed effectively with dietary changes or supplementation. Early detection and appropriate treatment typically lead to a good prognosis.
Disease Severity: Vitamin K deficiency can lead to serious health issues, primarily affecting blood clotting. Without sufficient vitamin K, the body cannot produce prothrombin, a protein essential for blood clotting. This can result in excessive bleeding, easy bruising, and increased bleeding risk from minor injuries. In severe cases, it can lead to hemorrhaging. In infants, vitamin K deficiency can cause bleeding in various parts of the body, which can be life-threatening. Regular intake of vitamin K through diet or supplements is essential to prevent these complications.
Healthcare Professionals: Disease Ontology ID - DOID:11249
Pathophysiology: Pathophysiology:
Vitamin K is crucial for synthesizing proteins required for blood clotting. A deficiency impairs the production of these clotting factors (e.g., prothrombin, factors VII, IX, and X), leading to an increased risk of bleeding and hemorrhage. It can also affect bone metabolism and lead to weakened bone structure. The deficiency may result from inadequate dietary intake, malabsorption conditions (such as celiac disease, Crohn's disease, or cystic fibrosis), or use of certain medications like antibiotics or anticoagulants.

Nan:
Not applicable or not available (N/A).
Carrier Status: Vitamin K deficiency is not associated with a carrier status, as it is not a genetic disorder. Instead, it is typically caused by insufficient dietary intake of vitamin K, malabsorption issues, or the use of certain medications that inhibit vitamin K metabolism.
Mechanism: Vitamin K deficiency primarily affects the blood clotting mechanism. Vitamin K is essential for the synthesis of certain proteins required for blood coagulation, such as prothrombin and factors VII, IX, and X. Without sufficient vitamin K, these clotting factors remain inactive, leading to an increased risk of bleeding.

Molecularly, vitamin K acts as a cofactor for the enzyme gamma-glutamyl carboxylase. This enzyme catalyzes the carboxylation of specific glutamic acid residues on the clotting factors to gamma-carboxyglutamic acid (Gla). The carboxylation process allows these proteins to bind calcium ions, which is necessary for their proper structural configuration and function in the coagulation cascade. In the absence of vitamin K, this carboxylation does not occur, and the clotting factors remain inactive.
Treatment: Treatment for vitamin K deficiency typically involves administering vitamin K, either orally or through injection. The specific method and dosage depend on the severity of the deficiency and the patient's individual circumstances. For mild cases, dietary adjustments to include vitamin K-rich foods might be recommended. In more severe cases, particularly if there is active bleeding or a high risk of bleeding, healthcare providers may use vitamin K injections. Treatment aims to restore normal vitamin K levels and address any underlying conditions contributing to the deficiency.
Compassionate Use Treatment: Vitamin K deficiency primarily requires supplementation with vitamin K, typically through oral or injectable forms. Compassionate use treatments and off-label or experimental treatments are less common, but some approaches may include:

1. **Compassionate Use Treatment**: Not typically applicable for vitamin K deficiency itself, as effective standard treatments are widely available. However, in severe cases or when complications arise, such as major bleeding, fresh frozen plasma may be used under compassionate circumstances to provide immediate clotting factors.

2. **Off-Label Treatments**: Occasionally, intravenous vitamin K may be used off-label in cases of severe bleeding or when oral administration is not feasible.

3. **Experimental Treatments**: There are limited experimental treatments specific to vitamin K deficiency, as the condition is well-managed with existing therapies. Research may focus on optimizing delivery methods or addressing specific populations at risk, such as patients on certain medications or those with malabsorption syndromes.

Always consult with a healthcare provider for the most appropriate and individualized treatment options.
Lifestyle Recommendations: For vitamin K deficiency, lifestyle recommendations include:

1. **Diet:** Increase intake of vitamin K-rich foods, such as leafy green vegetables (kale, spinach, broccoli, Brussels sprouts), and certain vegetable oils (soybean, canola). Fermented foods like natto (fermented soybeans) are also high in vitamin K2.

2. **Supplementation:** Consider vitamin K supplements, especially if dietary intake is insufficient. It's important to consult with a healthcare provider before starting any supplementation.

3. **Medications:** Be cautious with medications that affect vitamin K absorption or function, such as certain antibiotics, anticoagulants (warfarin), and cholesterol-lowering drugs. Regular monitoring and adjustment may be needed.

4. **Gut Health:** Maintain gut health, as some vitamin K is produced by gut bacteria. Probiotics and a balanced diet can support a healthy gut microbiome.

5. **Alcohol Consumption:** Limit alcohol consumption, as excessive drinking can impair vitamin K absorption and liver function, where vitamin K is stored and processed.

6. **Smoking:** Avoid smoking, which can negatively affect nutrient absorption and overall health.

By adhering to these lifestyle considerations, individuals can help prevent or manage vitamin K deficiency.
Medication: For vitamin K deficiency, the primary medication is vitamin K supplementation. This can be administered orally or through injections, depending on the severity of the deficiency. Common forms of vitamin K used include phytonadione (vitamin K1). In certain cases, particularly in newborns, a single injection of vitamin K1 is standard practice to prevent bleeding complications. If you have any specific concerns or symptoms, you should consult with a healthcare provider for personalized guidance.
Repurposable Drugs: For vitamin K deficiency, there aren't any specific drugs listed as repurposable because the primary treatment involves supplementing with vitamin K itself, either orally or via injection. The deficiency typically arises from either inadequate dietary intake, poor absorption, or use of medications that interfere with vitamin K metabolism, such as certain antibiotics or anticoagulants. Therefore, addressing the underlying cause and replenishing vitamin K is the main approach.
Metabolites: Vitamin K deficiency results in decreased levels of functional clotting factors, particularly prothrombin (Factor II), and Factors VII, IX, and X, which are all vitamin K-dependent metabolites. This deficiency can lead to bleeding disorders due to impaired blood clotting.
Nutraceuticals: For vitamin K deficiency, nutraceuticals commonly used include vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) supplements. These can be found in tablet, capsule, or liquid form. They help in the synthesis of proteins required for blood clotting and bone health. Addressing vitamin K deficiency promptly can prevent serious complications such as excessive bleeding and osteoporosis.
Peptides: Vitamin K deficiency, peptides, nan refers to synthetic or natural peptides designed to address or study aspects related to vitamin K deficiency. Nanotechnology (nan) can be used to enhance the delivery or effectiveness of these peptides in clinical or research settings. Specifically, vitamin K-dependent peptides may be crucial in coagulation and bone metabolism, which are significantly affected by vitamin K deficiency.